Roger Molto Pallares
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Roger Molto Pallares has a total of 264 co-authors. Here are the top co-authors by number of shared publications:
- Twan Lammers
Institute for Experimental Molecular Imaging (ExMI), RWTH Aachen University Hospital, Aachen, Germany
34 shared publications - Fabian Kiessling
Institute for Experimental Molecular Imaging RWTH Aachen University Aachen Germany
21 shared publications - Rebecca J. Abergel
University of California Berkeley
21 shared publications Fabian Kiessling
Institute for Experimental Molecular Imaging, RWTH Aachen University Hospital, Aachen 52074, Germany
20 shared publicationsRui Zhang
RWTH Aachen University Hospital
17 shared publicationsStephan Rütten
Electron Microscope Facility, Institute for Pathology, RWTH Aachen University Hospital, Aachen 52074, Germany
12 shared publications
Latest Publications
- 30 October 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
Machine Learning Modeling for Solubility Prediction in Pharmaceutical-Ionic Liquid Systems with Deep Feature Search
Drug solubility is a critical determinant of bioavailability and therapeutic efficacy in pharmaceutical development, with poorly soluble compounds presenting significant formulation challenges. Ionic liquids (ILs) have emerged as promising solubilizing agents due to their tunable physicochemical properties and ability to enhance drug dissolution. While machine learning (ML) has shown promise in predicting various IL properties, its application to pharmaceutical solubility prediction in IL media remains underexplored, largely due to the fragmented experimental data reported, the inherent complexity of binary (or multi-component) pharmaceutical−IL systems, and the susceptibility of conventional feature selection methods to overfitting on small datasets. This study addresses this gap by developing a data-driven quantitative structure−property relationship (QSPR) model for solubility prediction in pharmaceutical−IL systems. We curated a comprehensive experimental dataset comprising 234 solubility measurements spanning diverse pharmaceuticals and ILs (including binary IL mixtures, where IL1 and IL2 denote the two constituent ionic liquids) across varying temperatures. From SMILES representations of molecular structures, we computed 155 molecular descriptors using RDKit, followed by rigorous preprocessing including variance thresholding and Yeo-Johnson transformation. Two complementary feature selection strategies, deep feature selection (DFS) and SHapley Additive exPlanations (SHAP), were employed to identify the most predictive descriptors. Four regression models, including random forest (RF), extreme gradient boosting (XGB), decision tree (DT), and multilayer perceptron (MLP), were evaluated on the selected features. Under the adopted validation framework, DFS-selected features produced more consistent out-of-sample performance than SHAP-selected features, with XGB achieving the highest test performance (R2 = 0.84). While DFS prioritized structural descriptors (e.g., bicyclic rings and aromatic systems), SHAP analysis revealed that temperature and IL composition ratios exert the strongest influence on final predictions. This work establishes a reliable ML framework for solubility prediction in pharmaceutical−IL systems, providing valuable guidance for the rational design of IL-based drug delivery formulations.
- 30 October 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
Machine Learning Modeling for Solubility Prediction in Pharmaceutical-Ionic Liquid Systems with Deep Feature Search
Drug solubility is a critical determinant of bioavailability and therapeutic efficacy in pharmaceutical development, with poorly soluble compounds presenting significant formulation challenges. Ionic liquids (ILs) have emerged as promising solubilizing agents due to their tunable physicochemical properties and ability to enhance drug dissolution. While machine learning (ML) has shown promise in predicting various IL properties, its application to pharmaceutical solubility prediction in IL media remains underexplored, largely due to the fragmented experimental data reported, the inherent complexity of binary (or multi-component) pharmaceutical−IL systems, and the susceptibility of conventional feature selection methods to overfitting on small datasets. This study addresses this gap by developing a data-driven quantitative structure−property relationship (QSPR) model for solubility prediction in pharmaceutical−IL systems. We curated a comprehensive experimental dataset comprising 234 solubility measurements spanning diverse pharmaceuticals and ILs (including binary IL mixtures, where IL1 and IL2 denote the two constituent ionic liquids) across varying temperatures. From SMILES representations of molecular structures, we computed 155 molecular descriptors using RDKit, followed by rigorous preprocessing including variance thresholding and Yeo-Johnson transformation. Two complementary feature selection strategies, deep feature selection (DFS) and SHapley Additive exPlanations (SHAP), were employed to identify the most predictive descriptors. Four regression models, including random forest (RF), extreme gradient boosting (XGB), decision tree (DT), and multilayer perceptron (MLP), were evaluated on the selected features. Under the adopted validation framework, DFS-selected features produced more consistent out-of-sample performance than SHAP-selected features, with XGB achieving the highest test performance (R2 = 0.84). While DFS prioritized structural descriptors (e.g., bicyclic rings and aromatic systems), SHAP analysis revealed that temperature and IL composition ratios exert the strongest influence on final predictions. This work establishes a reliable ML framework for solubility prediction in pharmaceutical−IL systems, providing valuable guidance for the rational design of IL-based drug delivery formulations.
- Open Access
- 8 October 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (38) , 20684-20694
Route- and sex-dependent toxicity of clinical-stage silver nanoparticles in mice
We present a multi-endpoint preclinical safety assessment of the clinical stage silver nanomedicine Nowarta110 following repeated dermal topical, oral mucosal, and intravaginal administration in mice.
- 8 October 2026
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 18 (38) , 20684-20694
Open AccessRoute- and sex-dependent toxicity of clinical-stage silver nanoparticles in mice
We present a multi-endpoint preclinical safety assessment of the clinical stage silver nanomedicine Nowarta110 following repeated dermal topical, oral mucosal, and intravaginal administration in mice.
- Open Access
- 3 October 2026
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
Engineering Gold Nanoconstruct Architecture Dictates Absorption Efficiency and Photoacoustic Imaging Performance
Photoacoustic (PA) imaging combines the high contrast of optical modalities with the deep-tissue penetration and high-spatial resolution of ultrasound, making it an attractive technique for biomedical imaging. Gold nanoconstructs are among the most widely investigated PA imaging probes due to their strong, tunable optical extinction, and excellent photostability. However, despite extensive development of gold nanomaterials, the mechanisms through which nanoconstruct architecture influences PA performance remain incompletely understood, limiting the rational design of next-generation probes. Here, we investigate how engineering gold nanoconstruct architecture dictates PA imaging performance across the near-infrared window. Six gold nanoconstructs representing the three most (pre)clinically relevant architectural classes, namely nanostars, nanorods, and nanoshells, were developed and engineered to exhibit localized surface plasmon resonances centered at either 800 or 980 nm. Using a standardized framework comprising physicochemical characterization, biological studies, in vitro and ex vivo PA imaging, and quantitative PA point-source modeling, we established relationships between nanoconstruct architecture, absorption efficiency, and PA performance. All formulations generated concentration-dependent PA signals in vitro and detectable contrast in biological tissue ex vivo, while maintaining excellent photostability under continuous irradiation with a pulsed laser. Marked architecture-dependent differences were observed, with nanoshells and nanostars consistently outperforming nanorods (up to 5-fold), particularly those resonant at longer wavelengths, attributed to their higher absorption cross sections per nanoparticle volume, as determined by PA modeling. Beyond PA performance, nanostars and nanoshells also exhibited superior colloidal stability in biological media, whereas all formulations displayed minimal cytotoxicity. Among the investigated architectures, gold nanostars resonating at 980 nm emerged as a particularly promising candidate, combining strong PA signal generation with a size profile more favorable for in vivo applications. Collectively, these findings demonstrate that engineering gold nanoconstruct architecture manipulates absorption efficiency and consequently PA imaging performance, providing a framework for rational engineering of next-generation PA imaging probes.
- 3 October 2026
- Published by American Chemical Society (ACS) in Chemical & Biomedical Imaging
Open AccessEngineering Gold Nanoconstruct Architecture Dictates Absorption Efficiency and Photoacoustic Imaging Performance
Photoacoustic (PA) imaging combines the high contrast of optical modalities with the deep-tissue penetration and high-spatial resolution of ultrasound, making it an attractive technique for biomedical imaging. Gold nanoconstructs are among the most widely investigated PA imaging probes due to their strong, tunable optical extinction, and excellent photostability. However, despite extensive development of gold nanomaterials, the mechanisms through which nanoconstruct architecture influences PA performance remain incompletely understood, limiting the rational design of next-generation probes. Here, we investigate how engineering gold nanoconstruct architecture dictates PA imaging performance across the near-infrared window. Six gold nanoconstructs representing the three most (pre)clinically relevant architectural classes, namely nanostars, nanorods, and nanoshells, were developed and engineered to exhibit localized surface plasmon resonances centered at either 800 or 980 nm. Using a standardized framework comprising physicochemical characterization, biological studies, in vitro and ex vivo PA imaging, and quantitative PA point-source modeling, we established relationships between nanoconstruct architecture, absorption efficiency, and PA performance. All formulations generated concentration-dependent PA signals in vitro and detectable contrast in biological tissue ex vivo, while maintaining excellent photostability under continuous irradiation with a pulsed laser. Marked architecture-dependent differences were observed, with nanoshells and nanostars consistently outperforming nanorods (up to 5-fold), particularly those resonant at longer wavelengths, attributed to their higher absorption cross sections per nanoparticle volume, as determined by PA modeling. Beyond PA performance, nanostars and nanoshells also exhibited superior colloidal stability in biological media, whereas all formulations displayed minimal cytotoxicity. Among the investigated architectures, gold nanostars resonating at 980 nm emerged as a particularly promising candidate, combining strong PA signal generation with a size profile more favorable for in vivo applications. Collectively, these findings demonstrate that engineering gold nanoconstruct architecture manipulates absorption efficiency and consequently PA imaging performance, providing a framework for rational engineering of next-generation PA imaging probes.
- Open Access
- 14 September 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (35) , 14515-14531
Green surfactants reveal mechanistic principles governing polymeric microbubble formation and function
Greener non-ionic surfactants replace Triton X-100 in polymeric microbubble synthesis, revealing how hydrophobic tail structure, PEG length, and HLB engineer microbubble yield, morphology, shell composition, drug loading, and acoustic performance.
- 14 September 2026
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 28 (35) , 14515-14531
Open AccessGreen surfactants reveal mechanistic principles governing polymeric microbubble formation and function
Greener non-ionic surfactants replace Triton X-100 in polymeric microbubble synthesis, revealing how hydrophobic tail structure, PEG length, and HLB engineer microbubble yield, morphology, shell composition, drug loading, and acoustic performance.
- Top Cited PapersOpen Access
- 29 May 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (12) , 6704-6738
Clinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics
We present a large-scale scientometric (pre-)clinical landscape analysis of stimuli-responsive therapeutics, highlighting the impact of nano-/micro-scale material platforms, and mapping translational barriers and strategies to overcome them.
- 29 May 2026
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 55 (12) , 6704-6738
Top Cited PapersOpen AccessClinical translation and landscape of stimuli-responsive nanomedicines and microscale therapeutics
We present a large-scale scientometric (pre-)clinical landscape analysis of stimuli-responsive therapeutics, highlighting the impact of nano-/micro-scale material platforms, and mapping translational barriers and strategies to overcome them.
- 23 March 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 103 (4) , 2242-2249
Seedless Gold Nanostars: A Hands-On Educational Approach to Explore Plasmonic Effects at the Nanoscale
- 23 March 2026
- Published by American Chemical Society (ACS) in Journal of Chemical Education
- Vol. 103 (4) , 2242-2249
Seedless Gold Nanostars: A Hands-On Educational Approach to Explore Plasmonic Effects at the Nanoscale
- Open Access
- 7 March 2026
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 16 (10) , 3577-3588
Clinical translation and landscape of copper nanoparticles
Although the medical use of copper dates back millennia and medicines based on copper nanoparticles have been employed for over a century, their benefits are still often questioned. Over the past three decades, advances in nanotechnology have renewed interest in copper-based nanoformulations for healthcare. While most preclinical studies have focused on systemically administered copper nanomedicines for a broad range of therapeutic purposes, clinical trials remain scarce and are primarily centered on topical applications, where long-term off-target accumulation can be minimized to mitigate safety concerns. Despite exhibiting only moderate antiseptic activity compared with other inorganic nanomaterials, copper nanoparticles demonstrate significant wound healing potential through complex mechanisms involving angiogenesis promotion and stabilization of extracellular skin proteins. In this work, we discuss the current landscape of copper nanoparticles (and related microparticulate structures), and we thoroughly analyze the characteristics that have enabled their translation and use in clinical settings.
- 7 March 2026
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 16 (10) , 3577-3588
Open AccessClinical translation and landscape of copper nanoparticles
Although the medical use of copper dates back millennia and medicines based on copper nanoparticles have been employed for over a century, their benefits are still often questioned. Over the past three decades, advances in nanotechnology have renewed interest in copper-based nanoformulations for healthcare. While most preclinical studies have focused on systemically administered copper nanomedicines for a broad range of therapeutic purposes, clinical trials remain scarce and are primarily centered on topical applications, where long-term off-target accumulation can be minimized to mitigate safety concerns. Despite exhibiting only moderate antiseptic activity compared with other inorganic nanomaterials, copper nanoparticles demonstrate significant wound healing potential through complex mechanisms involving angiogenesis promotion and stabilization of extracellular skin proteins. In this work, we discuss the current landscape of copper nanoparticles (and related microparticulate structures), and we thoroughly analyze the characteristics that have enabled their translation and use in clinical settings.
- Open Access
- 14 February 2026
- Published by Elsevier in Journal of Controlled Release
- Vol. 392, 114726
Effect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation
- 14 February 2026
- Published by Elsevier in Journal of Controlled Release
- Vol. 392, 114726
Open AccessEffect of clinically relevant iron oxide nanoparticles on macrophage polarization, tumor growth and tumor microenvironment modulation
- 28 January 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (5) , 1848-1855
Real-Time Observation of Thermal Reshaping Mechanisms in Gold Nanostars
Gold nanostars (AuNS) exhibit morphology-dependent optical properties that make them attractive for photothermal and photoacoustic applications; however, their limited thermal stability remains a critical challenge. In this work, we investigate the thermal behavior of AuNS synthesized using Good's buffers, specifically 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid (EPPS) and 3-(N-morpholino)propanesulfonic acid (MOPS), by combining ex situ and in situ characterization techniques. Ex situ heating revealed collective deformation at elevated temperatures, while in situ heating enabled the real-time observation of individual particle reshaping. AuNS-EPPS displayed reshaping rates more than twice those of AuNS-MOPS, caused by both the thermal treatment and electron beam effects. Direct visualization revealed gold migration from branches to the core, a mechanism previously hypothesized. Despite pronounced morphological changes, the crystal structure remained intact. These results clarify the deformation mechanisms of AuNS and inform the design of more thermally robust nanostructures for (photo)thermal applications.
- 28 January 2026
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 26 (5) , 1848-1855
Real-Time Observation of Thermal Reshaping Mechanisms in Gold Nanostars
Gold nanostars (AuNS) exhibit morphology-dependent optical properties that make them attractive for photothermal and photoacoustic applications; however, their limited thermal stability remains a critical challenge. In this work, we investigate the thermal behavior of AuNS synthesized using Good's buffers, specifically 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid (EPPS) and 3-(N-morpholino)propanesulfonic acid (MOPS), by combining ex situ and in situ characterization techniques. Ex situ heating revealed collective deformation at elevated temperatures, while in situ heating enabled the real-time observation of individual particle reshaping. AuNS-EPPS displayed reshaping rates more than twice those of AuNS-MOPS, caused by both the thermal treatment and electron beam effects. Direct visualization revealed gold migration from branches to the core, a mechanism previously hypothesized. Despite pronounced morphological changes, the crystal structure remained intact. These results clarify the deformation mechanisms of AuNS and inform the design of more thermally robust nanostructures for (photo)thermal applications.
- Top Cited Papers
- 28 January 2026
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 126 (3) , 1949-2005
Multifunctional Ultrasound Microbubbles
Microbubbles (MBs) have served as ultrasound (US) contrast agents for over 30 years in cardiac imaging and liver tumor characterization. Moreover, in recent years, molecularly targeted MBs are currently under clinical evaluation for oncological and inflammatory diseases. Beyond diagnostics, MBs are gaining attention as therapeutic tools, leveraging their strong acoustic properties for US-mediated drug delivery, sonopermeation of biological barriers (i.e., the blood-brain barrier), and targeted thrombolysis. Loading MB shells with magnetic or optical functionalities allows therapy monitoring using magnetic resonance or photoacoustic imaging, aligning with recent multimodal advances in (pre)clinical device developments. Therefore, this review summarizes and critically assesses advances in the use of multifunctional MBs for biomedical applications. A comprehensive overview of existing MB formulations is provided, analyzing the primary types of functional agents incorporated, including small molecules, nanomaterials, and targeting ligands, as well as the conjugation and functionalization strategies involved in constructing next-generation MBs. Current trends in multifunctional MBs for imaging and therapy are critically evaluated, along with the challenges in their clinical translation. Overall, this review highlights the potential of multifunctional MBs to address unmet biomedical needs that plain additives cannot fulfill, and it showcases promising future directions for the diagnostic and therapeutic use of next-generation MB formulations.
- 28 January 2026
- Published by American Chemical Society (ACS) in Chemical Reviews
- Vol. 126 (3) , 1949-2005
Top Cited PapersMultifunctional Ultrasound Microbubbles
Microbubbles (MBs) have served as ultrasound (US) contrast agents for over 30 years in cardiac imaging and liver tumor characterization. Moreover, in recent years, molecularly targeted MBs are currently under clinical evaluation for oncological and inflammatory diseases. Beyond diagnostics, MBs are gaining attention as therapeutic tools, leveraging their strong acoustic properties for US-mediated drug delivery, sonopermeation of biological barriers (i.e., the blood-brain barrier), and targeted thrombolysis. Loading MB shells with magnetic or optical functionalities allows therapy monitoring using magnetic resonance or photoacoustic imaging, aligning with recent multimodal advances in (pre)clinical device developments. Therefore, this review summarizes and critically assesses advances in the use of multifunctional MBs for biomedical applications. A comprehensive overview of existing MB formulations is provided, analyzing the primary types of functional agents incorporated, including small molecules, nanomaterials, and targeting ligands, as well as the conjugation and functionalization strategies involved in constructing next-generation MBs. Current trends in multifunctional MBs for imaging and therapy are critically evaluated, along with the challenges in their clinical translation. Overall, this review highlights the potential of multifunctional MBs to address unmet biomedical needs that plain additives cannot fulfill, and it showcases promising future directions for the diagnostic and therapeutic use of next-generation MB formulations.